Plasma corticotrophin response to desmopressin in patients with Cushing's disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 253-263

  Wang, Fan Fen ^a   Tang, Kam Tsun ^b   Yen, Yu Shu ^c   Ho, Donald Ming Tak ^d   Yang, An Hang ^d   Hwang, Chun I ^c   Lin, Hong Da ^e   Won, Justin G S ^e  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b Departments of Medical Research and Education   (Taiwan)

^c Neurological Institute   (Taiwan)

^d Pathology ^*  (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DESMOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

ACTH SECRETING CELL; ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPHINOMA; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; FEMALE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS TUMOR; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; CORTICOTROPIN-RELEASING HORMONE; DEAMINO ARGININE VASOPRESSIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; RECEPTORS, VASOPRESSIN;

EID: 84855465683     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04179.x     Document Type: Article

References (45)

1. Orth, D.N., (1992) Corticotropin-releasing hormone in humans. Endocrine Reviews, 13, 164-191.
2. Orth, D.N., DeBold, C.R., DeCherney, G.S., et al. (1982) Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. Journal of Clinical Endocrinology and Metabolism, 55, 1017-1019. (Pubitemid 13054371)
3. Newell-Price, J., Bertagna, X., Grossman, A.B., et al. (2006) Cushing's syndrome. Lancet, 367, 1605-1617. (Pubitemid 43674231)
4. Raux, M.C., Binoux, M., Luton, J.P., et al. (1973) Studies of ACTH secretion control in 116 cases of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 40, 186-197.
5. Richardson, D.W., &, Robinson, A.G., (1985) Desmopressin. Annals of Internal Medicine, 103, 228-239. (Pubitemid 15000578)
6. Malerbi, D.A., Mendonça, B.B., Liberman, B., et al. (1993) The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology, 38, 463-472. (Pubitemid 23153407)
7. Colombo, P., Passini, E., Re, T., et al. (1997) Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clinical Endocrinology, 46, 661-668. (Pubitemid 27304450)
8. Malerbi, D.A., Fragoso, M.C., Vieira Filho, A.H., et al. (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness. Journal of Clinical Endocrinology and Metabolism, 81, 2233-2237. (Pubitemid 26175951)
9. Suda, T., Kageyama, K., Nigawara, T., et al. (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome. Endocrine Journal, 56, 469-476.
10. Tirabassi, G., Faloia, E., Papa, R., et al. (2010) Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 95, 1115-1122.
11. Maybauer, M.O., Maybauer, D.M., Enkhbaatar, P., et al. (2008) Physiology of the vasopressin receptors. Best Practice & Research Clinical Anaesthesiology, 22, 253-263. (Pubitemid 351804049)
12. Mandon, B., Bellanger, A.C., &, Elalouf, J.M., (1995) Inverse PCR-mediated cloning of the promoter for the rat vasopressin V2 receptor gene. Pflügers Archiv: European Journal of Physiology, 430, 12-18.
13. Watters, J.J., Swank, M.W., Wilkinson, C.W., et al. (1996) Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene. Peptides, 17, 67-73.
14. Rabadan-Diehl, C., Makara, G., Kiss, A., et al. (1997) Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. Endocrinology, 138, 5189-5194. (Pubitemid 27509677)
15. Dahia, P.L., Ahmed-Shuaib, A., Jacobs, R.A., et al. (1996) Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism, 81, 1768-1771.
16. de Keyzer, Y., René, P., Beldjord, C., et al. (1998) Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clinical Endocrinology, 49, 475-482. (Pubitemid 28475340)
17. Saris, S.C., Patronas, N.J., Doppman, J.L., et al. (1987) Cushing syndrome: pituitary CT scanning. Radiology, 162, 775-777. (Pubitemid 17019211)
18. Colombo, N., Loli, P., Vignati, F., et al. (1994) MR of corticotropin-secreting pituitary microadenomas. American Journal of Neuroradiology, 15, 1591-1595. (Pubitemid 24285916)
19. Hardy, J., (1979) Transsphenoidal microsurgical treatment of pituitary tumours. In:, J. Linfoot, ed. Recent Advances in the Diagnosis and Treatment of Pituitary Tumour. Raven Press, New York, 375-388.
20. Kaye, T.B., &, Crapo, L., (1990) The Cushing syndrome: an update on diagnostic tests. Annals of Internal Medicine, 112, 434-444. (Pubitemid 20098525)
21. Bobrow, M.N., Harris, T.D., Shaughnessy, K.J., et al. (1989) Catalyzed reporter deposition, a novel method of signal amplification: application to immunoassays. Journal of Immunological Methods, 125, 279-285. (Pubitemid 20018033)
22. Volante, M., Pecchioni, C., &, Bussolati, G., (2000) Post-incubation heating significantly improves tyramide signal amplification. Journal of Histochemistry and Cytochemistry, 48, 1583-1585.
23. Wu, K.D., Chen, Y.M., Chu, T.S., et al. (2001) Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma. Journal of Clinical Endocrinology and Metabolism, 86, 4460-4467.
24. Armitage, P., Berry, G., &, Matthews, J.N.S., (2002) Statistical Methods in Medical Research. 4th ed. Blackwell Science, Oxford, 312-377.
25. Di Chiro, G., &, Nelson, K.B., (1962) The volume of the sella turcica. American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, 87, 989-1008.
26. Heuser, I.F., Gotthardt, T., Schweiger, U., et al. (1994) Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiology of Aging, 15, 227-231. (Pubitemid 24120831)
27. Kunugi, H., Ida, I., Owashi, T., et al. (2006) Assessment of the Dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary- adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology, 31, 212-220. (Pubitemid 43250958)
28. Selvais, P., Donckier, J., Buysschaert, M., et al. (1998) Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. European Journal of Endocrinology, 138, 153-159. (Pubitemid 28131091)
29. Findling, J.W., &, Raff, H., (1999) Newer diagnostic techniques and problems in Cushing's disease. Endocrinology and Metabolism Clinics of North America, 28, 191-210. (Pubitemid 29164784)
30. Abe, T., Tachikawa, T., Sasaki, A., et al. (2000) Histopathological and physiological characteristics of cultured human ACTH-secreting cells derived from a rapidly growing pituitary adenoma. Brain Tumor Pathology, 17, 133-138.
31. Saito, M., Tahara, A., &, Sugimoto, T., (1997) 1-desamino-8-d- arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. Biochemical Pharmacology, 53, 1711-1717. (Pubitemid 27356101)
32. Machado, M.C., Valeria de Sa, S., Correa-Giannella, M.L., et al. (2008) Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients. European Journal of Endocrinology, 158, 605-613. (Pubitemid 351639597)
33. Sakai, Y., Horiba, N., Tozawa, F., et al. (1997) Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome. Endocrine Journal, 44, 687-695. (Pubitemid 28011457)
34. Pecori Giraldi, F., Marini, E., Torchiana, E., et al. (2003) Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness. Journal of Endocrinology, 177, 373-379. (Pubitemid 36722292)
35. Aguilera, G., Volpi, S., &, Rabadan-Diehl, C., (2003) Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene. Journal of Molecular Endocrinology, 30, 99-108. (Pubitemid 36592504)
36. Orcel, H., Tobin, V.A., Alonso, G., et al. (2002) Immunocytochemical localization of vasopressin V1a receptors in the rat pituitary gonadotropes. Endocrinology, 143, 4385-4388. (Pubitemid 35239572)
37. Lee, S., Hwang, R., Lee, J., et al. (2005) Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clinical Endocrinology, 63, 625-630. (Pubitemid 41779634)
38. Louiset, E., Contesse, V., Groussin, L., et al. (2008) Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. Journal of Endocrinology, 196, 1-9. (Pubitemid 351234566)
39. North, W.G., Fay, M.J., Longo, K.A., et al. (1998) Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Research, 58, 1866-1871. (Pubitemid 28217460)
40. Dieterich, K.D., Gundelfinger, E.D., Lüdecke, D.K., et al. (1998) Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 83, 3327-3331. (Pubitemid 28500980)
41. Suda, T., Tomori, N., Tozawa, F., et al. (1984) Effects of corticotrophin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro. Journal of Clinical Endocrinology and Metabolism, 55, 840-845. (Pubitemid 14020681)
42. 0-hCRH labeling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophs. Neurochemistry International, 30, 291-297. (Pubitemid 27055441)
43. Jia, L.G., Canny, B.J., Orth, D.N., et al. (1991) Distinct classes of corticotropes mediate corticotrophin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology, 128, 197-203.
44. Chiodera, P., Volpi, R., Bianconcini, M., et al. (2002) Comments, opinions, and brief case reports: desmopressin test in occult eutopic corticotropin microadenoma. Archives of Internal Medicine, 162, 840-841. (Pubitemid 34273311)
45. Tsagarakis, S., Tsigos, C., Vasiliou, V., et al. (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. Journal of Clinical Endocrinology and Metabolism, 87, 1646-1653. (Pubitemid 34615253)